This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to enhance national risk-based control plans and surveillance plans for pharmacologically active substances. The regulation updates requirements for submitting data by Member States, sampling frequencies, and minimum percentages of samples for substance group A(3), point (b).
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested